FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2901667064> ?p ?o ?g. }

• W2901667064 endingPage "92" @default.
• W2901667064 startingPage "83" @default.
• W2901667064 abstract "Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date Álvaro Machado,1 Tiago Torres1,2 1Department of Dermatology, Centro Hospitalar Universitário do Porto, Porto, Portugal; 2Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal Abstract: Psoriasis is a common chronic immune-mediated skin disease, with systemic involvement and significant impact in patients’ quality of life. Several highly specific treatments have been developed over the years, such as tumor necrosis factor-α inhibitors, a nonselective IL-23 inhibitor (ustekinumab), and most recently IL-17 inhibitors. Risankizumab is a monoclonal antibody which targets IL-23p19 without binding IL-12. This novel therapeutic approach is expected to have advantages over the recently approved anti-IL-17 agents, such as the avoidance of Candida infections and neutropenia. In addition, unlike ustekinumab, the selective inhibition of IL-23 may preserve IL-12-dependent functions such as protection against infections and tumor immune surveillance. Risankizumab showed an excellent efficacy when compared to placebo and ustekinumab, with higher Psoriasis Area Severity Index (PASI) 75, PASI 90, and PASI 100 rates, along with a convenient every 12-week maintenance dosing regimen. Overall, risankizumab was well tolerated and the most common adverse event was upper respiratory tract infection. In the near future, further data will be available not only in psoriasis but also in Crohn’s disease and psoriatic arthritis fields. Head-to-head trials comparing risankizumab with other IL-23 inhibitors and with IL-17 inhibitors will be crucial to reveal the role of risankizumab in the treatment of psoriasis. Keywords: psoriasis, IL-23, risankizumab" @default.
• W2901667064 created "2018-11-29" @default.
• W2901667064 creator A5075250734 @default.
• W2901667064 creator A5077025645 @default.
• W2901667064 date "2018-11-01" @default.
• W2901667064 modified "2023-10-17" @default.
• W2901667064 title "Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date" @default.
• W2901667064 cites W1510081630 @default.
• W2901667064 cites W1661616496 @default.
• W2901667064 cites W1895297599 @default.
• W2901667064 cites W1939997832 @default.
• W2901667064 cites W1957267795 @default.
• W2901667064 cites W1966226308 @default.
• W2901667064 cites W1973354423 @default.
• W2901667064 cites W1984399057 @default.
• W2901667064 cites W1991524518 @default.
• W2901667064 cites W2003425690 @default.
• W2901667064 cites W2003687140 @default.
• W2901667064 cites W2021018799 @default.
• W2901667064 cites W2062561385 @default.
• W2901667064 cites W2063871323 @default.
• W2901667064 cites W2064645845 @default.
• W2901667064 cites W2080165152 @default.
• W2901667064 cites W2083340757 @default.
• W2901667064 cites W2092466307 @default.
• W2901667064 cites W2096877370 @default.
• W2901667064 cites W2098282839 @default.
• W2901667064 cites W2116956799 @default.
• W2901667064 cites W2171889601 @default.
• W2901667064 cites W2257545295 @default.
• W2901667064 cites W2413203763 @default.
• W2901667064 cites W2418506270 @default.
• W2901667064 cites W2464558465 @default.
• W2901667064 cites W2499510596 @default.
• W2901667064 cites W2517289120 @default.
• W2901667064 cites W2521243079 @default.
• W2901667064 cites W2533384923 @default.
• W2901667064 cites W2558568353 @default.
• W2901667064 cites W2587193484 @default.
• W2901667064 cites W2606035821 @default.
• W2901667064 cites W2606398981 @default.
• W2901667064 cites W2611353171 @default.
• W2901667064 cites W2620306249 @default.
• W2901667064 cites W2701201582 @default.
• W2901667064 cites W2725559229 @default.
• W2901667064 cites W2730335164 @default.
• W2901667064 cites W2740634127 @default.
• W2901667064 cites W2749689947 @default.
• W2901667064 cites W2752721387 @default.
• W2901667064 cites W2783502763 @default.
• W2901667064 cites W2790698850 @default.
• W2901667064 cites W2793057982 @default.
• W2901667064 cites W2883739562 @default.
• W2901667064 cites W2884146134 @default.
• W2901667064 cites W2884774799 @default.
• W2901667064 cites W2887313024 @default.
• W2901667064 cites W2887412253 @default.
• W2901667064 cites W2888489614 @default.
• W2901667064 cites W2890147164 @default.
• W2901667064 cites W4233998745 @default.
• W2901667064 cites W4248269869 @default.
• W2901667064 doi "https://doi.org/10.2147/ptt.s165943" @default.
• W2901667064 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6239126" @default.
• W2901667064 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30519540" @default.
• W2901667064 hasPublicationYear "2018" @default.
• W2901667064 type Work @default.
• W2901667064 sameAs 2901667064 @default.
• W2901667064 citedByCount "9" @default.
• W2901667064 countsByYear W29016670642020 @default.
• W2901667064 countsByYear W29016670642022 @default.
• W2901667064 countsByYear W29016670642023 @default.
• W2901667064 crossrefType "journal-article" @default.
• W2901667064 hasAuthorship W2901667064A5075250734 @default.
• W2901667064 hasAuthorship W2901667064A5077025645 @default.
• W2901667064 hasBestOaLocation W29016670641 @default.
• W2901667064 hasConcept C126322002 @default.
• W2901667064 hasConcept C156730664 @default.
• W2901667064 hasConcept C16005928 @default.
• W2901667064 hasConcept C197934379 @default.
• W2901667064 hasConcept C203014093 @default.
• W2901667064 hasConcept C2777011040 @default.
• W2901667064 hasConcept C2778975655 @default.
• W2901667064 hasConcept C2779134260 @default.
• W2901667064 hasConcept C2780132546 @default.
• W2901667064 hasConcept C2780564577 @default.
• W2901667064 hasConcept C3020604521 @default.
• W2901667064 hasConcept C47348012 @default.
• W2901667064 hasConcept C71924100 @default.
• W2901667064 hasConcept C8891405 @default.
• W2901667064 hasConceptScore W2901667064C126322002 @default.
• W2901667064 hasConceptScore W2901667064C156730664 @default.
• W2901667064 hasConceptScore W2901667064C16005928 @default.
• W2901667064 hasConceptScore W2901667064C197934379 @default.
• W2901667064 hasConceptScore W2901667064C203014093 @default.
• W2901667064 hasConceptScore W2901667064C2777011040 @default.
• W2901667064 hasConceptScore W2901667064C2778975655 @default.
• W2901667064 hasConceptScore W2901667064C2779134260 @default.
• W2901667064 hasConceptScore W2901667064C2780132546 @default.

• next